Spotlight -

VMS and Menopause|

Atopic Dermatitis Provider Toolkit|

Adult Immunization Provider Toolkit|

Dermatology Hot Topics

Interactive Posters

Upcoming|Archived

Finerenone and Cardiorenal Outcomes by History of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease: FIDELITY Analyses

Finerenone and Cardiorenal Outcomes by History of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease: FIDELITY Analyses

Date:

October 3rd 2022, 2:46 pm EDT

Finerenone in Patients With CKD and T2D by SGLT-2i Treatment: The Fidelity Prespecified Pooled Analysis

Finerenone in Patients With CKD and T2D by SGLT-2i Treatment: The Fidelity Prespecified Pooled Analysis

Date:

October 3rd 2022, 3:15 pm EDT

Trending on Patient Care Online

FDA Approves Guselkumab for Pediatric Plaque Psoriasis and Active Psoriatic Arthritis

Lipocine Updates Progress on Phase 3 Clinical Trial in Postpartum Depression with LPCN 1154

Cannabis Extract Provides LBP Relief Superior to Opioids Over 12 Months in Phase 3 Clinical Trial

Measles Outbreak Fails to Push MMR Rates to Herd Immunity Levels, Study Reveals

10 Drugs Approved for Primary Care From the First Half of 2025

© 2025 MJH Life Sciences^®

All rights reserved.